| 14.8 -0.4 (-2.63%) | 10-24 14:58 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 18.87 | 1-year : | 22.04 |
| Resists | First : | 16.15 | Second : | 18.87 |
| Pivot price | 14.34 |
|||
| Supports | First : | 13.35 | Second : | 11.61 |
| MAs | MA(5) : | 15.16 |
MA(20) : | 14.32 |
| MA(100) : | 16.11  |
MA(250) : | 14.27 |
|
| MACD | MACD : | 0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 74.6 |
D(3) : | 77.8 |
| RSI | RSI(14): 52.8 |
|||
| 52-week | High : | 25.35 | Low : | 0.77 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ OM ] has closed below upper band by 40.2%. Bollinger Bands are 19% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 15.96 - 16.05 | 16.05 - 16.13 |
| Low: | 14.73 - 14.85 | 14.85 - 14.95 |
| Close: | 15.04 - 15.2 | 15.2 - 15.35 |
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Thu, 23 Oct 2025
Outset Medical, Inc. (OM) Investor Outlook: Unveiling a 71% Potential Upside with Innovative Hemodialysis Solutions - DirectorsTalk Interviews
Thu, 16 Oct 2025
Outset Medical, Inc. (OM) Stock Analysis: Navigating Potential Upside with an Innovative Edge - DirectorsTalk Interviews
Mon, 29 Sep 2025
Stifel reaffirms Buy rating on Outset Medical stock at $17 price target - Investing.com
Mon, 22 Sep 2025
Outset Medical: Revenue Trajectory Yet To Reflect Favorable Demand Tailwinds (NASDAQ:OM) - Seeking Alpha
Wed, 20 Aug 2025
Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference - GlobeNewswire
Wed, 06 Aug 2025
Outset Medical Q2 Earnings: Revenue Jumps 15%, Raises Full-Year Guidance to $126M - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 18 (M) |
| Shares Float | 11 (M) |
| Held by Insiders | 2.7 (%) |
| Held by Institutions | 105.4 (%) |
| Shares Short | 1,720 (K) |
| Shares Short P.Month | 1,950 (K) |
| EPS | -18.75 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.5 |
| Profit Margin | -82.1 % |
| Operating Margin | -53.7 % |
| Return on Assets (ttm) | -15.8 % |
| Return on Equity (ttm) | -87.7 % |
| Qtrly Rev. Growth | 14.6 % |
| Gross Profit (p.s.) | 2.46 |
| Sales Per Share | 6.71 |
| EBITDA (p.s.) | -4 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -68 (M) |
| Levered Free Cash Flow | -35 (M) |
| PE Ratio | -0.79 |
| PEG Ratio | 0 |
| Price to Book value | 1.73 |
| Price to Sales | 2.2 |
| Price to Cash Flow | -3.89 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|